Flexion Therapeutics, Inc. Deferred Revenue
Flexion Therapeutics, Inc. had Deferred Revenue of $10.00 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2021-11-12
- 2021-09-30: Deferred Revenue, Current $10.00M.
- 2021-06-30: Deferred Revenue, Current $10.00M.
- 2021-03-31: Deferred Revenue, Current $10.00M.
- 2020-12-31: Deferred Revenue, Current $10.00M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2021-09-30 | $10.00M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $10.00M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $10.00M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $10.00M 10-Q · filed 2021-11-12 |
| 2020-09-30 | $10.00M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $5.00M 10-Q · filed 2020-08-05 |